156 related articles for article (PubMed ID: 7498327)
1. Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice.
Fornai F; Bassi L; Torracca MT; Scalori V; Corsini GU
Eur J Pharmacol; 1995 Sep; 283(1-3):99-102. PubMed ID: 7498327
[TBL] [Abstract][Full Text] [Related]
2. Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice.
Marien M; Briley M; Colpaert F
Eur J Pharmacol; 1993 Jun; 236(3):487-9. PubMed ID: 7689466
[TBL] [Abstract][Full Text] [Related]
3. Noradrenergic modulation of methamphetamine-induced striatal dopamine depletion.
Fornai F; Alessandrì MG; Torracca MT; Bassi L; Scalori V; Corsini GU
Ann N Y Acad Sci; 1998 May; 844():166-77. PubMed ID: 9668674
[TBL] [Abstract][Full Text] [Related]
4. Effects of pretreatment with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on methamphetamine pharmacokinetics and striatal dopamine losses.
Fornai F; Giorgi FS; Alessandrì MG; Giusiani M; Corsini GU
J Neurochem; 1999 Feb; 72(2):777-84. PubMed ID: 9930753
[TBL] [Abstract][Full Text] [Related]
5. Norepinephrine loss selectively enhances chronic nigrostriatal dopamine depletion in mice and rats.
Fornai F; Torracca MT; Bassi L; D'Errigo DA; Scalori V; Corsini GU
Brain Res; 1996 Oct; 735(2):349-53. PubMed ID: 8911678
[TBL] [Abstract][Full Text] [Related]
6. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
Fornai F; Alessandrì MG; Torracca MT; Bassi L; Corsini GU
J Pharmacol Exp Ther; 1997 Oct; 283(1):100-7. PubMed ID: 9336313
[TBL] [Abstract][Full Text] [Related]
7. Morphological and biochemical evidence that apomorphine rescues striatal dopamine terminals and prevents methamphetamine toxicity.
Battaglia G; Gesi M; Lenzi P; Busceti CL; Soldani P; Orzi F; Rampello L; Nicoletti F; Ruggieri S; Fornai F
Ann N Y Acad Sci; 2002 Jun; 965():254-66. PubMed ID: 12105101
[TBL] [Abstract][Full Text] [Related]
8. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine pretreatment attenuates methamphetamine-induced dopamine toxicity.
Kita T; Saraya T; Konishi N; Matsunari Y; Shimada K; Nakamura M; O'Hara K; Wagner GC; Nakashima T
Pharmacol Toxicol; 2003 Feb; 92(2):71-80. PubMed ID: 12747576
[TBL] [Abstract][Full Text] [Related]
9. Noradrenergic Modulation of Methamphetamine-Induced Striatal Dopamine Depletion.
Fornai F; Alessandrì MG; Torrac MT; Bassi L; Scalori V; Corsini GU
Ann N Y Acad Sci; 1998 May; 844(1):166-177. PubMed ID: 29090815
[TBL] [Abstract][Full Text] [Related]
10. Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH2-MPTP): a comparative study with 2'-CH3-MPTP and MPTP.
Andrews AM; Murphy DL
J Neurochem; 1993 Mar; 60(3):1167-70. PubMed ID: 8094744
[TBL] [Abstract][Full Text] [Related]
11. Dimebon attenuates methamphetamine, but not MPTP, striatal dopamine depletion.
Geldenhuys WJ; Darvesh AS; Dluzen DE
Neurochem Int; 2012 Jun; 60(8):806-8. PubMed ID: 22710395
[TBL] [Abstract][Full Text] [Related]
12. Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
Lau YS; Trobough KL; Crampton JM; Wilson JA
Gen Pharmacol; 1990; 21(2):181-7. PubMed ID: 2332138
[TBL] [Abstract][Full Text] [Related]
13. Methamphetamine protects against MPTP neurotoxicity in C57BL mice.
Sziráki I; Kardos V; Patthy M; Pátfalusi M; Budai G
Eur J Pharmacol; 1994 Jan; 251(2-3):311-4. PubMed ID: 8149986
[TBL] [Abstract][Full Text] [Related]
14. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
Chan P; Langston JW; Di Monte DA
J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813
[TBL] [Abstract][Full Text] [Related]
15. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Holmer HK; Keyghobadi M; Moore C; Meshul CK
Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485
[TBL] [Abstract][Full Text] [Related]
16. Methamphetamine-induced neurotoxicity in BALB/c, DBA/2N and C57BL/6N mice.
Kita T; Paku S; Takahashi M; Kubo K; Wagner GC; Nakashima T
Neuropharmacology; 1998 Sep; 37(9):1177-84. PubMed ID: 9833648
[TBL] [Abstract][Full Text] [Related]
17. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
Nishi K; Kondo T; Narabayashi H
No To Shinkei; 1987 Jul; 39(7):663-72. PubMed ID: 3314916
[TBL] [Abstract][Full Text] [Related]
18. Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP.
Hemrick-Luecke SK; Robertson DW; Krushinski JH; Fuller RW
Life Sci; 1992; 50(8):573-82. PubMed ID: 1736028
[TBL] [Abstract][Full Text] [Related]
19. [The effect of prolyl-leucyl-glycine (MIF-1) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine levels of the striatum].
Sheng JG
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Aug; 22(4):213-5, 253. PubMed ID: 2575971
[TBL] [Abstract][Full Text] [Related]
20. Partial protection from the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by Pro-Leu-Gly-NH2(PLG; MIF-1).
Sheng JG; Xu DL; Yu HZ; Xu XR; Tang QM
Life Sci; 1987 May; 40(20):2007-10. PubMed ID: 2437428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]